EBITDA

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.

After a record 2025 but a mixed Q4, the aerospace supplier's upcoming earnings will reveal its resilience against renewed supply chain disruptions.

With its third acquisition in 10 months, Pinnaql, backed by 3 Boomerang Capital, is rapidly building a one-stop-shop for life sciences advisory.

After dominating the utility sector, tax software firm Lucasys is now signing major oil & gas clients, signaling a strategic shake-up in energy finance.

Fort Worth’s Paslay Group acquires LA-based Trifiletti Consulting, expanding into new sectors and strengthening its hold on the California market.

A new platform is launching AI-powered interviews and scheduling at a fraction of the cost of enterprise tools, promising to change how businesses hire.

Former HHS Secretary Tommy Thompson joins Vector Science & Therapeutics, leveraging his political clout to advance a novel transdermal drug delivery platform.

ProPetro posts a Q1 loss due to weather but reveals a massive power generation expansion with Caterpillar, betting big on data centers and microgrids.

The energy services giant posts strong Q1 results, capitalizing on a strategic industry shift to offshore projects for enhanced energy security and profits.

Mineral driller Foraco posts 20% revenue growth in Q1, but aggressive expansion and new contract costs take a heavy toll on short-term profits and margins.

With double-digit growth and key US acquisitions, ESTEVE is rapidly expanding. But it's the firm's B Corp status that may redefine success in pharma.

Taiwanese firm Smart Power System unveils an AI-driven strategy to build disaster-proof microgrids and export its advanced energy technology worldwide.

Backed by a licensing powerhouse, the new group House of IP aims to merge patent protection with monetization, acquiring Patentwerk in a strategic first move.

The £87M take-private deal merges VertiGIS's applications with 1Spatial's data expertise, aiming to dominate the AI-driven geospatial solutions market.

Aker Solutions posts solid Q1 results with a massive order intake, rewarding shareholders while strategically pivoting towards emerging markets like nuclear energy.

Arcadis reports robust Q1 order intake and improved margins, leaning on its new AI Studio and strategic streamlining to navigate a complex global market.

New at-home tests for IBS and SIBO are gaining validation, promising faster diagnoses and revealing surprising links between gut health and systemic diseases.

A landmark A$3.9 billion deal takes Australia's wealth giant Insignia Financial private, signaling a new era for the nation's superannuation sector.

The new San Gabriel mine powers a 139% profit surge for the Peruvian miner, which also sees strong silver, lead, and zinc output and a robust cash position.